Name | Value |
---|---|
Revenues | 297.5K |
Cost of Revenue | 110.8K |
Gross Profit | 186.7K |
Operating Expense | 2,031.0K |
Operating I/L | -1,844.3K |
Other Income/Expense | -466.7K |
Interest Income | 13.1K |
Pretax | -2,311.0K |
Income Tax Expense | 0.0K |
Net Income/Loss | -2,311.0K |
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company specializing in licensing and commercializing medical devices and biomaterials for treating afflictions and diseases in animals. Its flagship product, Kush, is a veterinarian-administered joint injection designed to address osteoarthritis and lameness in dogs and horses. The company's revenue is generated through the sale and licensing of these medical devices and biomaterials, with a pipeline of 17 therapeutic devices for veterinary and human clinical applications.